Compounds > cyclosporine

cyclosporine and Hereditary Optic Neuroretinopathy

cyclosporine has been researched along with Hereditary Optic Neuroretinopathy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amati-Bonneau, P; Bonneau, D; Lenaers, G; Leruez, S; Miléa, D; Orssaud, C; Procaccio, V; Prundean, A; Reynier, P; Rougier, MB; Scherer, C; Tilikete, C; Verny, C; Zanlonghi, X1
Fatima, A; Gieseler, A; Haroon, MF; Horn, TF; Kirches, E; Kreutzmann, P; Schöler, S; Wolf, G1

Trials

1 trial(s) available for cyclosporine and Hereditary Optic Neuroretinopathy

ArticleYear
Cyclosporine A does not prevent second-eye involvement in Leber's hereditary optic neuropathy.
    Orphanet journal of rare diseases, 2018, 02-17, Volume: 13, Issue:1

    Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Optic Atrophy, Hereditary, Leber; Pilot Projects; Young Adult

2018

Other Studies

1 other study(ies) available for cyclosporine and Hereditary Optic Neuroretinopathy

ArticleYear
Minocycline, a possible neuroprotective agent in Leber's hereditary optic neuropathy (LHON): studies of cybrid cells bearing 11,778 mutation.
    Neurobiology of disease, 2007, Volume: 28, Issue:3

    Topics: Acetylcholine; Analysis of Variance; Calcium; Cell Death; Cholinergic Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Hybrid Cells; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Minocycline; Mutation; Neuroprotective Agents; Optic Atrophy, Hereditary, Leber; Thapsigargin; Time Factors

2007